Updated:
Caisse de Pension de la Société Suisse de Pharmacie
Founded in 1959 by pharmaSuisse, the Swiss Society of Pharmacists, Caisse de Pension de la Société Suisse de Pharmacie (CPSSPH) began as a modest scheme...
Caisse de Pension de la Société Suisse de Pharmacie
Founded in 1959 by pharmaSuisse, the Swiss Society of Pharmacists, Caisse de Pension de la Société Suisse de Pharmacie (CPSSPH) began as a modest scheme for a single profession and expanded meaningfully in 1985 when Switzerland's second pillar became mandatory for employees. The fund serves pharmacies, individual pharmacists, cantonal pharmacy societies, and health-sector employers tied to the pharmaceutical branch, all governed by a parity-based foundation board that seats four employer and four employee representatives. CPSSPH deploys capital across a deliberately diversified set of asset classes. Its real estate exposure includes direct ownership of the office building at Rue Pedro-Meylan 7 in Geneva and participation in the Prisma Global Residential Real Estate vehicle. The fund commits to private markets through buyout funds, general venture funds, and fund-of-funds strategies, and it holds a dedicated Insurance Linked Strategies allocation. A domestic private credit program operates via FWI Prêts aux PME CHF, a lending vehicle for Swiss small and medium enterprises. The fund's investment architecture relies heavily on two co-investment platforms: Prisma Fondation, a professional investment foundation where Philipp Aegerter serves as President, and Fondation Winterthur, where Aegerter chairs the Investment Controlling Committee. CPSSPH's investment governance is anchored by Philipp Aegerter, the named operative who presides over the two foundations that handle the fund's co-investment and lending activities. The fund is a member of ASIP, the Swiss pension fund association, and maintains administrative links to OFAC, the billing office for Swiss pharmacists, which shares its Geneva headquarters. In September 2023, the fund updated its data protection declarations to comply with Switzerland's new Federal Act on Data Protection (LPD), reflecting the operational adjustments typical of Swiss pension institutions managing regulated member data. CPSSPH's structural differentiator lies in its foundation-based co-investment model. Rather than managing assets entirely in-house or delegating to a single external manager, the fund acts as a member-investor in Prisma Fondation, a dedicated investment foundation that pools capital from multiple pension funds to access real estate and private market strategies. This structure gives CPSSPH the scale and diversification benefits of a pooled vehicle while preserving the governance role through Aegerter's presidency, creating a hybrid that sits between a pure direct investor and a passive limited partner.
General information
Firm type
Pension Fund
Year founded
1959
AUM
$1.45B (Altss estimate)
Location
Region
Europe
Country
Switzerland
City
Geneva
Corporate office
7 Rue Pedro-Meylan, 1208 Geneva, Switzerland
Principals
Philipp Aegerter
President, Prisma Fondation and Investment Controlling Committee, FWI
Sector focus
Frequently asked questions
Who runs investment decisions at Caisse de Pension de la Société Suisse de Pharmacie?
Philipp Aegerter is the named individual overseeing investment governance. He is the President of Prisma Fondation, the investment foundation through which CPSSPH accesses real estate and private markets, and chairs the Investment Controlling Committee at Fondation Winterthur, which manages the FWI Prêts aux PME CHF lending program. Day-to-day management of the fund is overseen by the parity-based foundation board, composed of four employer and four employee representatives.
How is CPSSPH related to pharmaSuisse?
pharmaSuisse, the Swiss Society of Pharmacists, founded CPSSPH in 1959 to provide pension coverage for Swiss pharmacists and pharmacies. pharmaSuisse itself is eligible to affiliate with the fund under Article 3 of the fund's regulations, and the fund serves pharmacies, individual pharmacists, and other entities whose activities are linked to the pharmaceutical sector.
Does CPSSPH invest directly or through external managers?
CPSSPH operates a hybrid model. It directly owns real estate, including a commercial building at 7 Rue Pedro-Meylan in Geneva, and participates in pooled investment foundations such as Prisma Fondation and Fondation Winterthur. The fund also commits to external buyout, venture, and fund-of-funds managers, and holds a dedicated insurance-linked securities allocation.
What role does Prisma Fondation play in CPSSPH's portfolio?
Prisma Fondation is a professional investment foundation that pools capital from Swiss pension funds, including CPSSPH, to access private real estate and other alternative strategies. CPSSPH is a member and investor in Prisma, and Philipp Aegerter, the key investment operative for CPSSPH, serves as its President, linking the fund's governance directly to the foundation's investment decisions.
What is CPSSPH's exposure to private credit?
The fund participates in a domestic private credit strategy through FWI Prêts aux PME CHF, a vehicle managed via Fondation Winterthur that provides loans to Swiss small and medium enterprises. Philipp Aegerter chairs the Investment Controlling Committee at Fondation Winterthur, which oversees this lending activity.
Has CPSSPH publicly disclosed its total assets under management?
No. CPSSPH does not publish a consolidated AUM figure on its website or in publicly available documents. Altss estimates the fund's total assets at approximately $1.45 billion based on structured research into its real estate holdings, foundation commitments, and private-market allocations.
What is CPSSPH's relationship with OFAC?
OFAC, the billing office for Swiss pharmacists, shares CPSSPH's headquarters at 7 Rue Pedro-Meylan in Geneva and maintains administrative ties to the fund. The two entities are structurally linked through their common sponsorship by the Swiss pharmacist community, though CPSSPH operates independently as a regulated pension institution.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: